Want to see BDRX full AI Analyst Report?
Biodexa Pharmaceuticals (BDRX) Financial Statements
Biodexa Pharmaceuticals Financial Overview
Biodexa Pharmaceuticals's market cap is currently $1.80M. The company's EPS TTM is $-0.04; its P/E ratio is -64.02; Biodexa Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 381.00K | $ 699.00K | $ 578.00K |
| Gross Profit | $ -184.86K | $ -5.44M | $ -3.69M | $ -4.41M | $ -4.08M |
| Operating Income | $ -8.27M | $ -9.20M | $ -8.01M | $ -8.93M | $ -7.00M |
| EBITDA | $ -8.08M | $ -8.95M | $ -7.16M | $ -8.09M | $ -5.66M |
| Net Income | $ -6.24M | $ -5.73M | $ -7.08M | $ -7.66M | $ -5.46M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 8.52M | $ 1.67M | $ 5.97M | $ 2.84M | $ 10.06M |
| Total Assets | $ 18.15M | $ 14.78M | $ 10.54M | $ 5.53M | $ 12.91M |
| Total Debt | $ 60.89K | $ 727.00K | $ 464.00K | $ 624.00K | $ 766.00K |
| Net Debt | $ -8.46M | $ -942.00K | $ -5.51M | $ -2.21M | $ -9.29M |
| Total Liabilities | $ 6.76M | $ 6.46M | $ 5.86M | $ 2.36M | $ 2.46M |
| Stockholders' Equity | $ 11.38M | $ 8.32M | $ 4.68M | $ 3.16M | $ 10.45M |
| Cash Flow | |||||
| Free Cash Flow | $ -5.40M | $ -13.04M | $ -7.09M | $ -7.11M | $ -6.33M |
| Operating Cash Flow | $ -5.39M | $ -12.26M | $ -6.83M | $ -7.05M | $ -6.01M |
| Investing Cash Flow | $ -658.25K | $ -598.00K | $ -265.00K | $ -220.00K | $ -278.00K |
| Financing Cash Flow | $ 12.77M | $ 8.56M | $ 10.23M | $ 47.00K | $ 8.80M |
Currency in GBP